{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:37:47Z","timestamp":1789659467499,"version":"4.0.1"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774210"],"award-info":[{"award-number":["81774210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["YY-033"],"award-info":[{"award-number":["YY-033"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013088","name":"Qinglan Project of Jiangsu Province of China","doi-asserted-by":"publisher","award":["2020"],"award-info":[{"award-number":["2020"]}],"id":[{"id":"10.13039\/501100013088","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Acupuncture & Chronobiology Key Laboratory of Sichuan Province","award":["2021005"],"award-info":[{"award-number":["2021005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11302-022-09856-4","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T03:04:33Z","timestamp":1646622273000},"page":"229-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Purinergic signaling in myocardial ischemia\u2013reperfusion injury"],"prefix":"10.1007","volume":"19","author":[{"given":"Yi","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-feng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"issue":"10053","key":"9856_CR1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/s0140-6736(16)31012-1","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2016","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1459\u20131544. https:\/\/doi.org\/10.1016\/s0140-6736(16)31012-1","journal-title":"Lancet"},{"issue":"3","key":"9856_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijcard.2013.11.007","volume":"170","author":"FJ Bernink","year":"2014","unstructured":"Bernink FJ, Timmers L, Beek AM, Diamant M, Roos ST, Van Rossum AC, Appelman Y (2014) Progression in attenuating myocardial reperfusion injury: an overview. Int J Cardiol 170(3):261\u2013269. https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.007","journal-title":"Int J Cardiol"},{"issue":"11","key":"9856_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1056\/NEJMe1509718","volume":"373","author":"DJ Hausenloy","year":"2015","unstructured":"Hausenloy DJ, Yellon DM (2015) Targeting myocardial reperfusion injury\u2013the search continues. N Engl J Med 373(11):1073\u20131075. https:\/\/doi.org\/10.1056\/NEJMe1509718","journal-title":"N Engl J Med"},{"issue":"2","key":"9856_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijcard.2004.04.013","volume":"100","author":"AL Moens","year":"2005","unstructured":"Moens AL, Claeys MJ, Timmermans JP, Vrints CJ (2005) Myocardial ischemia\/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100(2):179\u2013190. https:\/\/doi.org\/10.1016\/j.ijcard.2004.04.013","journal-title":"Int J Cardiol"},{"issue":"11","key":"9856_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357(11):1121\u20131135. https:\/\/doi.org\/10.1056\/NEJMra071667","journal-title":"N Engl J Med"},{"issue":"3","key":"9856_CR6","first-page":"509","volume":"24","author":"G Burnstock","year":"1972","unstructured":"Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24(3):509\u2013581","journal-title":"Pharmacol Rev"},{"key":"9856_CR7","first-page":"107","volume-title":"Cell membrane receptors for drugs and hormones: a multidisciplinary approach","author":"G Burnstock","year":"1978","unstructured":"Burnstock G (1978) A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L (eds) Cell membrane receptors for drugs and hormones: a multidisciplinary approach. Raven Press, New York, pp 107\u2013118"},{"issue":"3","key":"9856_CR8","first-page":"413","volume":"50","author":"V Ralevic","year":"1998","unstructured":"Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50(3):413\u2013492","journal-title":"Pharmacol Rev"},{"issue":"1","key":"9856_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1517\/14728222.2011.541441","volume":"15","author":"VE Laubach","year":"2011","unstructured":"Laubach VE, French BA, Okusa MD (2011) Targeting of adenosine receptors in ischemia-reperfusion injury. Expert Opin Ther Targets 15(1):103\u2013118. https:\/\/doi.org\/10.1517\/14728222.2011.541441","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"9856_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","volume":"6","author":"Z Huang","year":"2021","unstructured":"Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang CH, Tang Y (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6(1):162. https:\/\/doi.org\/10.1038\/s41392-021-00553-z","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"9856_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","volume":"68","author":"AN Drury","year":"1929","unstructured":"Drury AN, Szent-Gy\u00f6rgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68(3):213\u2013237. https:\/\/doi.org\/10.1113\/jphysiol.1929.sp002608","journal-title":"J Physiol"},{"issue":"1","key":"9856_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","volume":"140","author":"JP Headrick","year":"2013","unstructured":"Headrick JP, Ashton KJ, Rose\u2019meyer RB, Peart JN (2013) Cardiovascular adenosine receptors: expression, actions and interactions. Pharmacol Ther 140(1):92\u2013111. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.06.002","journal-title":"Pharmacol Ther"},{"issue":"1","key":"9856_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","volume":"120","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signaling in the cardiovascular system. Circ Res 120(1):207\u2013228. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309726","journal-title":"Circ Res"},{"key":"9856_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.phrs.2018.12.009","volume":"141","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Matsumoto T, Jankowski V, Pernow J, Mustafa SJ, Duncker DJ, Merkus D (2019) Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update. Pharmacol Res 141:32\u201345. https:\/\/doi.org\/10.1016\/j.phrs.2018.12.009","journal-title":"Pharmacol Res"},{"issue":"4","key":"9856_CR15","doi-asserted-by":"publisher","first-page":"H723","DOI":"10.1152\/ajpheart.00417.2020","volume":"319","author":"B Wernly","year":"2020","unstructured":"Wernly B, Zhou Z (2020) More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease. Am J Physiol Heart Circ Physiol 319(4):H723\u2013H729. https:\/\/doi.org\/10.1152\/ajpheart.00417.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"9856_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11302-020-09734-x","volume":"17","author":"V Ralevic","year":"2021","unstructured":"Ralevic V (2021) Purinergic signalling in the cardiovascular system-a tribute to Geoffrey Burnstock. Purinergic Signal 17(1):63\u201369. https:\/\/doi.org\/10.1007\/s11302-020-09734-x","journal-title":"Purinergic Signal"},{"key":"9856_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.autneu.2015.04.007","volume":"191","author":"V Ralevic","year":"2015","unstructured":"Ralevic V, Dunn WR (2015) Purinergic transmission in blood vessels. Auton Neurosci 191:48\u201366. https:\/\/doi.org\/10.1016\/j.autneu.2015.04.007","journal-title":"Auton Neurosci"},{"key":"9856_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.vph.2017.12.063","volume":"103\u2013105","author":"ZSB Abbas","year":"2018","unstructured":"Abbas ZSB, Latif ML, Dovlatova N, Fox SC, Heptinstall S, Dunn WR, Ralevic V (2018) UDP-sugars activate P2Y14 receptors to mediate vasoconstriction of the porcine coronary artery. Vascul Pharmacol 103\u2013105:36\u201346. https:\/\/doi.org\/10.1016\/j.vph.2017.12.063","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"9856_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/pr.113.008029","volume":"66","author":"G Burnstock","year":"2014","unstructured":"Burnstock G, Ralevic V (2014) Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 66(1):102\u2013192. https:\/\/doi.org\/10.1124\/pr.113.008029","journal-title":"Pharmacol Rev"},{"issue":"2","key":"9856_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.abb.2003.09.029","volume":"420","author":"HA Sadek","year":"2003","unstructured":"Sadek HA, Nulton-Persson AC, Szweda PA, Szweda L (2003) Cardiac ischemia\/reperfusion, aging, and redox-dependent alterations in mitochondrial function. Arch Biochem Biophys 420(2):201\u2013208. https:\/\/doi.org\/10.1016\/j.abb.2003.09.029","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"9856_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0022-5223(19)38568-X","volume":"90","author":"SW Ely","year":"1985","unstructured":"Ely SW, Mentzer RM Jr, Lasley RD, Berne RM (1985) Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg 90(4):549\u2013556","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"9856_CR22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.cir.85.3.893","volume":"85","author":"SW Ely","year":"1992","unstructured":"Ely SW, Berne RM (1992) Protective effects of adenosine in myocardial ischemia. Circulation 85(3):893\u2013904. https:\/\/doi.org\/10.1161\/01.cir.85.3.893","journal-title":"Circulation"},{"issue":"6 Pt 2","key":"9856_CR23","doi-asserted-by":"publisher","first-page":"H1952","DOI":"10.1152\/ajpheart.1989.257.6.H1952","volume":"257","author":"DA Wyatt","year":"1989","unstructured":"Wyatt DA, Edmunds MC, Berne RM, Lasley RD, Mentzer RM Jr (1989) Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A1-adenosine receptors. Am J Physiol 257(6 Pt 2):H1952-1957. https:\/\/doi.org\/10.1152\/ajpheart.1989.257.6.H1952","journal-title":"Am J Physiol"},{"issue":"4","key":"9856_CR24","first-page":"445","volume":"103","author":"R Mainwaring","year":"1988","unstructured":"Mainwaring R, Lasley R, Rubio R, Wyatt DA, Mentzer RM Jr (1988) Adenosine stimulates glucose uptake in the isolated rat heart. Surgery 103(4):445\u2013449","journal-title":"Surgery"},{"issue":"5","key":"9856_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1006\/jmcc.1998.0672","volume":"30","author":"JP Headrick","year":"1998","unstructured":"Headrick JP, Gauthier NS, Berr SS, Morrison RR, Matherne GP (1998) Transgenic A1 adenosine receptor overexpression markedly improves myocardial energy state during ischemia-reperfusion. J Mol Cell Cardiol 30(5):1059\u20131064. https:\/\/doi.org\/10.1006\/jmcc.1998.0672","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"9856_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1067\/mtc.2000.107521","volume":"120","author":"BJ Pomerantz","year":"2000","unstructured":"Pomerantz BJ, Robinson TN, Morrell TD, Heimbach JK, Banerjee A, Harken AH (2000) Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium. J Thorac Cardiovasc Surg 120(2):387\u2013392. https:\/\/doi.org\/10.1067\/mtc.2000.107521","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"9856_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s003950200016","volume":"97","author":"RJ Cerniway","year":"2002","unstructured":"Cerniway RJ, Morrison RR, Byford AM, Lankford AR, Headrick JP, Van Wylen DG, Matherne GP (2002) A1 adenosine receptor overexpression decreases stunning from anoxia-reoxygenation: role of the mitochondrial K(ATP) channel. Basic Res Cardiol 97(3):232\u2013238. https:\/\/doi.org\/10.1007\/s003950200016","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"9856_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s0735-1097(99)00493-3","volume":"35","author":"T Miura","year":"2000","unstructured":"Miura T, Liu Y, Kita H, Ogawa T, Shimamoto K (2000) Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation. J Am Coll Cardiol 35(1):238\u2013245. https:\/\/doi.org\/10.1016\/s0735-1097(99)00493-3","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"9856_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10557-013-6489-2","volume":"28","author":"CH Leung","year":"2014","unstructured":"Leung CH, Wang LX, Nielsen JM, Tropak MB, Fu YY, Kato H, Callahan J, Redington AN, Caldarone CA (2014) Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation. Cardiovasc Drugs Ther 28(1):7\u201317. https:\/\/doi.org\/10.1007\/s10557-013-6489-2","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"9856_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/jmcc.1996.0262","volume":"29","author":"JC Cleveland Jr","year":"1997","unstructured":"Cleveland JC Jr, Meldrum DR, Rowland RT, Banerjee A, Harken A (1997) Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive K+ channel. J Mol Cell Cardiol 29(1):175\u2013182. https:\/\/doi.org\/10.1006\/jmcc.1996.0262","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"9856_CR31","doi-asserted-by":"publisher","first-page":"H1690","DOI":"10.1152\/ajpheart.2000.279.4.H1690","volume":"279","author":"JP Headrick","year":"2000","unstructured":"Headrick JP, Gauthier NS, Morrison R, Matherne GP (2000) Cardioprotection by K(ATP) channels in wild-type hearts and hearts overexpressing A(1)-adenosine receptors. Am J Physiol Heart Circ Physiol 279(4):H1690-1697. https:\/\/doi.org\/10.1152\/ajpheart.2000.279.4.H1690","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"9856_CR32","doi-asserted-by":"publisher","first-page":"H228","DOI":"10.1152\/ajpheart.1999.277.1.H228","volume":"277","author":"VH Thourani","year":"1999","unstructured":"Thourani VH, Nakamura M, Ronson RS, Jordan JE, Zhao ZQ, Levy JH, Szlam F, Guyton RA, Vinten-Johansen J (1999) Adenosine A(3)-receptor stimulation attenuates postischemic dysfunction through K(ATP) channels. Am J Physiol 277(1):H228-235. https:\/\/doi.org\/10.1152\/ajpheart.1999.277.1.H228","journal-title":"Am J Physiol"},{"issue":"1","key":"9856_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/s0008-6363(98)00112-6","volume":"40","author":"WR Tracey","year":"1998","unstructured":"Tracey WR, Magee W, Masamune H, Oleynek JJ, Hill RJ (1998) Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5\u2019-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation. Cardiovasc Res 40(1):138\u2013145. https:\/\/doi.org\/10.1016\/s0008-6363(98)00112-6","journal-title":"Cardiovasc Res"},{"issue":"3","key":"9856_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/jmcc.2001.1510","volume":"34","author":"TC Zhao","year":"2002","unstructured":"Zhao TC, Kukreja RC (2002) Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel. J Mol Cell Cardiol 34(3):263\u2013277. https:\/\/doi.org\/10.1006\/jmcc.2001.1510","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"9856_CR35","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1161\/01.cir.102.8.902","volume":"102","author":"T Zhao","year":"2000","unstructured":"Zhao T, Xi L, Chelliah J, Levasseur JE, Kukreja RC (2000) Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice. Circulation 102(8):902\u2013907. https:\/\/doi.org\/10.1161\/01.cir.102.8.902","journal-title":"Circulation"},{"issue":"1","key":"9856_CR36","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1038\/s41598-019-48006-6","volume":"9","author":"L Benoist","year":"2019","unstructured":"Benoist L, Chadet S, Genet T, Lefort C, Heraud A, Danila MD, Muntean DM, Baron C, Angoulvant D, Babuty D, Bourguignon T, Ivanes F (2019) Stimulation of P2Y11 receptor protects human cardiomyocytes against hypoxia\/reoxygenation injury and involves PKC\u03b5 signaling pathway. Sci Rep 9(1):11613. https:\/\/doi.org\/10.1038\/s41598-019-48006-6","journal-title":"Sci Rep"},{"key":"9856_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cca.2018.01.032","volume":"479","author":"Z Chen","year":"2018","unstructured":"Chen Z, He L, Li L, Chen L (2018) The P2X7 purinergic receptor: an emerging therapeutic target in cardiovascular diseases. Clin Chim Acta 479:196\u2013207. https:\/\/doi.org\/10.1016\/j.cca.2018.01.032","journal-title":"Clin Chim Acta"},{"issue":"2","key":"9856_CR38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/s0008-6363(01)00471-0","volume":"53","author":"R Zucchi","year":"2002","unstructured":"Zucchi R, Cerniway RJ, Ronca-Testoni S, Morrison RR, Ronca G, Matherne GP (2002) Effect of cardiac A(1) adenosine receptor overexpression on sarcoplasmic reticulum function. Cardiovasc Res 53(2):326\u2013333. https:\/\/doi.org\/10.1016\/s0008-6363(01)00471-0","journal-title":"Cardiovasc Res"},{"issue":"1","key":"9856_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s0008-6363(00)00318-7","volume":"50","author":"R Zucchi","year":"2001","unstructured":"Zucchi R, Yu G, Ghelardoni S, Ronca F, Ronca-Testoni S (2001) A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca(2+) release in rat heart. Cardiovasc Res 50(1):56\u201364. https:\/\/doi.org\/10.1016\/s0008-6363(00)00318-7","journal-title":"Cardiovasc Res"},{"issue":"4","key":"9856_CR40","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1172\/JCI114547","volume":"85","author":"BN Cronstein","year":"1990","unstructured":"Cronstein BN, Daguma L, Nichols D, Hutchison AJ, Williams M (1990) The adenosine\/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest 85(4):1150\u20131157. https:\/\/doi.org\/10.1172\/JCI114547","journal-title":"J Clin Invest"},{"issue":"3","key":"9856_CR41","doi-asserted-by":"publisher","first-page":"H949","DOI":"10.1152\/ajpheart.00741.2001","volume":"282","author":"Z Yang","year":"2002","unstructured":"Yang Z, Cernniway RJ, Byford AM, Berr SS, French BA, Matherne GP (2002) Cardiac overexpression of A1-adenosine receptor protects intact mice against myocardial infarction. Am J Physiol Heart Circ Physiol 282(3):H949-955. https:\/\/doi.org\/10.1152\/ajpheart.00741.2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"9856_CR42","doi-asserted-by":"publisher","first-page":"H1895","DOI":"10.1152\/ajpheart.1999.277.5.H1895","volume":"277","author":"JE Jordan","year":"1999","unstructured":"Jordan JE, Thourani VH, Auchampach JA, Robinson JA, Wang NP, Vinten-Johansen J (1999) A(3) adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am J Physiol 277(5):H1895-1905. https:\/\/doi.org\/10.1152\/ajpheart.1999.277.5.H1895","journal-title":"Am J Physiol"},{"issue":"4","key":"9856_CR43","doi-asserted-by":"publisher","first-page":"H1751","DOI":"10.1152\/ajpheart.2001.281.4.H1751","volume":"281","author":"RJ Cerniway","year":"2001","unstructured":"Cerniway RJ, Yang Z, Jacobson MA, Linden J, Matherne GP (2001) Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium. Am J Physiol Heart Circ Physiol 281(4):H1751-1758. https:\/\/doi.org\/10.1152\/ajpheart.2001.281.4.H1751","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5806","key":"9856_CR44","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1126\/science.1132559","volume":"314","author":"Y Chen","year":"2006","unstructured":"Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG (2006) ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314(5806):1792\u20131795. https:\/\/doi.org\/10.1126\/science.1132559","journal-title":"Science"},{"issue":"3","key":"9856_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/CIRCULATIONAHA.116.023365","volume":"136","author":"N Borg","year":"2017","unstructured":"Borg N, Alter C, G\u00f6rldt N, Jacoby C, Ding Z, Steckel B, Quast C, B\u00f6nner F, Friebe D, Temme S, Fl\u00f6gel U, Schrader J (2017) CD73 on T Cells orchestrates cardiac wound healing after myocardial infarction by purinergic metabolic reprogramming. Circulation 136(3):297\u2013313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023365","journal-title":"Circulation"},{"issue":"2","key":"9856_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/0267659115586579","volume":"31","author":"D Boros","year":"2016","unstructured":"Boros D, Thompson J, Larson DF (2016) Adenosine regulation of the immune response initiated by ischemia reperfusion injury. Perfusion 31(2):103\u2013110. https:\/\/doi.org\/10.1177\/0267659115586579","journal-title":"Perfusion"},{"issue":"2","key":"9856_CR47","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.pharmthera.2007.02.004","volume":"114","author":"JN Peart","year":"2007","unstructured":"Peart JN, Headrick JP (2007) Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol Ther 114(2):208\u2013221. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.02.004","journal-title":"Pharmacol Ther"},{"key":"9856_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.yjmcc.2019.12.011","volume":"139","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhang Y, Zhang J, Zhai T, Hu J, Luo H, Zhou H, Zhang Q, Zhou Z, Liu F (2020) Cathelicidin aggravates myocardial ischemia\/reperfusion injury via activating TLR4 signaling and P2X7R\/NLRP3 inflammasome. J Mol Cell Cardiol 139:75\u201386. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.12.011","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"9856_CR49","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","volume":"123","author":"M Kawaguchi","year":"2011","unstructured":"Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U (2011) Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury. Circulation 123(6):594\u2013604. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.982777","journal-title":"Circulation"},{"issue":"1","key":"9856_CR50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvt091","volume":"99","author":"\u00d8 Sandanger","year":"2013","unstructured":"Sandanger \u00d8, Ranheim T, Vinge LE, Bliks\u00f8en AK, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, Fitzgerald KA, Lien E, Valen G, Espevik T, Aukrust P, Yndestad A (2013) The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res 99(1):164\u2013174. https:\/\/doi.org\/10.1093\/cvr\/cvt091","journal-title":"Cardiovasc Res"},{"key":"9856_CR51","doi-asserted-by":"publisher","first-page":"654425","DOI":"10.3389\/fphar.2021.654425","volume":"12","author":"J Zhou","year":"2021","unstructured":"Zhou J, Zhou Z, Liu X, Yin HY, Tang Y, Cao X (2021) P2X7 receptor-mediated inflammation in cardiovascular disease. Front Pharmacol 12:654425. https:\/\/doi.org\/10.3389\/fphar.2021.654425","journal-title":"Front Pharmacol"},{"issue":"2","key":"9856_CR52","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/1074248409360356","volume":"15","author":"DA Vessey","year":"2010","unstructured":"Vessey DA, Li L, Kelley M (2010) Pannexin-I\/P2X7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning. J Cardiovasc Pharmacol Ther 15(2):190\u2013195. https:\/\/doi.org\/10.1177\/1074248409360356","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"3","key":"9856_CR53","doi-asserted-by":"publisher","first-page":"H881","DOI":"10.1152\/ajpheart.00305.2011","volume":"301","author":"DA Vessey","year":"2011","unstructured":"Vessey DA, Li L, Kelley M (2011) P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1\/P2X7 channels. Am J Physiol Heart Circ Physiol 301(3):H881-887. https:\/\/doi.org\/10.1152\/ajpheart.00305.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1\u20132","key":"9856_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11010-011-0713-9","volume":"351","author":"DA Vessey","year":"2011","unstructured":"Vessey DA, Li L, Kelley M (2011) Ischemic preconditioning requires opening of pannexin-1\/P2X(7) channels not only during preconditioning but again after index ischemia at full reperfusion. Mol Cell Biochem 351(1\u20132):77\u201384. https:\/\/doi.org\/10.1007\/s11010-011-0713-9","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"9856_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.4049\/jimmunol.1500197","volume":"195","author":"S Chadet","year":"2015","unstructured":"Chadet S, Ivanes F, Benoist L, Salmon-Gandonni\u00e8re C, Guibon R, Velge-Roussel F, Babuty D, Baron C, Roger S, Angoulvant D (2015) Hypoxia\/reoxygenation inhibits P2Y11 receptor expression and its immunosuppressive activity in human dendritic cells. J Immunol 195(2):651\u2013660. https:\/\/doi.org\/10.4049\/jimmunol.1500197","journal-title":"J Immunol"},{"key":"9856_CR56","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yjmcc.2018.07.245","volume":"121","author":"C Lefort","year":"2018","unstructured":"Lefort C, Benoist L, Chadet S, Piollet M, Heraud A, Babuty D, Baron C, Ivanes F, Angoulvant D (2018) Stimulation of P2Y11 receptor modulates cardiac fibroblasts secretome toward immunomodulatory and protective roles after hypoxia\/reoxygenation injury. J Mol Cell Cardiol 121:212\u2013222. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.07.245","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"9856_CR57","doi-asserted-by":"publisher","first-page":"413","DOI":"10.17219\/acem\/133139","volume":"30","author":"L Wang","year":"2021","unstructured":"Wang L, Li N, Wang F, Cui L (2021) P2Y12 inhibition in macrophages reduces ventricular arrhythmias in rats after myocardial ischemia-reperfusion. Adv Clin Exp Med 30(4):413\u2013420. https:\/\/doi.org\/10.17219\/acem\/133139","journal-title":"Adv Clin Exp Med"},{"issue":"7","key":"9856_CR58","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/cvr\/cvz070","volume":"115","author":"M Ziegler","year":"2019","unstructured":"Ziegler M, Wang X, Peter K (2019) Platelets in cardiac ischaemia\/reperfusion injury: a promising therapeutic target. Cardiovasc Res 115(7):1178\u20131188. https:\/\/doi.org\/10.1093\/cvr\/cvz070","journal-title":"Cardiovasc Res"},{"key":"9856_CR59","doi-asserted-by":"publisher","first-page":"8703627","DOI":"10.1155\/2020\/8703627","volume":"2020","author":"G Patti","year":"2020","unstructured":"Patti G, Micieli G, Cimminiello C, Bolognese L (2020) The role of clopidogrel in 2020: a reappraisal. Cardiovasc Ther 2020:8703627. https:\/\/doi.org\/10.1155\/2020\/8703627","journal-title":"Cardiovasc Ther"},{"issue":"8","key":"9856_CR60","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/mca.0000000000000663","volume":"29","author":"T Yokota","year":"2018","unstructured":"Yokota T, Higuma T, Endo T, Nishizaki F, Hanada K, Yokoyama H, Yamada M, Okumura K, Tomita H (2018) Prasugrel versus clopidogrel for residual thrombus burden in patients with ST-segment elevation myocardial infarction: an optical coherence tomography study. Coron Artery Dis 29(8):663\u2013669. https:\/\/doi.org\/10.1097\/mca.0000000000000663","journal-title":"Coron Artery Dis"},{"issue":"11","key":"9856_CR61","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.4244\/eijv9I11A226","volume":"9","author":"A Pandit","year":"2014","unstructured":"Pandit A, Aryal MR, Pandit AA, Jalota L, Hakim FA, Mookadam F, Lee HR, Tleyjeh IM (2014) Cangrelor versus clopidogrel in percutaneous coronary intervention: a systematic review and meta-analysis. EuroIntervention 9(11):1350\u20131358. https:\/\/doi.org\/10.4244\/eijv9I11A226","journal-title":"EuroIntervention"},{"issue":"1","key":"9856_CR62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1160\/TH09-07-0440","volume":"104","author":"JA Barrab\u00e9s","year":"2010","unstructured":"Barrab\u00e9s JA, Inserte J, Mirabet M, Quiroga A, Hernando V, Figueras J, Garcia-Dorado D (2010) Antagonism of P2Y12 or GPIIb\/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts. Thromb Haemost 104(1):128\u2013135. https:\/\/doi.org\/10.1160\/TH09-07-0440","journal-title":"Thromb Haemost"},{"issue":"8","key":"9856_CR63","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1161\/ARVBAHA.115.305655","volume":"35","author":"Y Ye","year":"2015","unstructured":"Ye Y, Birnbaum GD, Perez-Polo JR, Nanhwan MK, Nylander S, Birnbaum Y (2015) Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol 35(8):1805\u20131814. https:\/\/doi.org\/10.1161\/ARVBAHA.115.305655","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10233","key":"9856_CR64","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0140-6736(20)30325-1","volume":"395","author":"M Gimbel","year":"2020","unstructured":"Gimbel M, Qaderdan K, Willemsen L, Hermanides R, Bergmeijer T, Very E, Heestermans T, Gin MTJ, Waalewijn R, Hofma S, Hartog F, Jukema W, Birgelen C, Voskuil M, Kelder J, Deneer V, Berg JT (2020) Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet 395(10233):1374\u20131381. https:\/\/doi.org\/10.1016\/S0140-6736(20)30325-1","journal-title":"Lancet"},{"issue":"11","key":"9856_CR65","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Investigators P, Freij A, Th\u00f3rsen M (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045\u20131057. https:\/\/doi.org\/10.1056\/NEJMoa0904327","journal-title":"N Engl J Med"},{"issue":"20","key":"9856_CR66","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, Servi SD, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001\u20132015. https:\/\/doi.org\/10.1056\/NEJMoa0706482","journal-title":"N Engl J Med"},{"issue":"5","key":"9856_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10557-015-6609-2","volume":"29","author":"RM Bell","year":"2015","unstructured":"Bell RM, Sivaraman V, Kunuthur SP, Cohen MV, Downey JM, Yellon DM (2015) Cardioprotective properties of the platelet P2Y12 receptor inhibitor, Cangrelor: protective in diabetics and reliant upon the presence of blood. Cardiovasc Drugs Ther 29(5):415\u2013418. https:\/\/doi.org\/10.1007\/s10557-015-6609-2","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"9856_CR68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10557-015-6633-2","volume":"30","author":"MV Cohen","year":"2016","unstructured":"Cohen MV, Yang XM, White J, Yellon DM, Bell RM, Downey JM (2016) Cangrelor-mediated cardioprotection requires platelets and sphingosine phosphorylation. Cardiovasc Drugs Ther 30(2):229\u2013232. https:\/\/doi.org\/10.1007\/s10557-015-6633-2","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"9856_CR69","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s43440-019-00046-5","volume":"72","author":"T Dost","year":"2020","unstructured":"Dost T (2020) Cardioprotective properties of the platelet P2Y(12) receptor inhibitor prasugrel on cardiac ischemia\/reperfusion injury. Pharmacol Rep 72(3):672\u2013679. https:\/\/doi.org\/10.1007\/s43440-019-00046-5","journal-title":"Pharmacol Rep"},{"issue":"23","key":"9856_CR70","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1182\/blood-2016-03-707844","volume":"128","author":"R Aungraheeta","year":"2016","unstructured":"Aungraheeta R, Conibear A, Butler M, Kelly E, Nylander S, Mumford A, Mundell SJ (2016) Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor. Blood 128(23):2717\u20132728. https:\/\/doi.org\/10.1182\/blood-2016-03-707844","journal-title":"Blood"},{"issue":"2","key":"9856_CR71","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1074248413511693","volume":"19","author":"D Armstrong","year":"2014","unstructured":"Armstrong D, Summers C, Ewart L, Nylander S, Sidaway JE, Giezen J (2014) Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1. J Cardiovasc Pharmacol Ther 19(2):209\u2013219. https:\/\/doi.org\/10.1177\/1074248413511693","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"21","key":"9856_CR72","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/j.lfs.2005.09.035","volume":"78","author":"AJ Zatta","year":"2006","unstructured":"Zatta AJ, Matherne GP, Headrick JP (2006) Adenosine receptor-mediated coronary vascular protection in post-ischemic mouse heart. Life Sci 78(21):2426\u20132437. https:\/\/doi.org\/10.1016\/j.lfs.2005.09.035","journal-title":"Life Sci"},{"issue":"2","key":"9856_CR73","doi-asserted-by":"publisher","first-page":"H368","DOI":"10.1152\/ajpheart.1999.276.2.H368","volume":"276","author":"CH Huang","year":"1999","unstructured":"Huang CH, Kim SJ, Ghaleh B, Kudej RK, Shen YT, Bishop SP, Vatner SF (1999) An adenosine agonist and preconditioning shift the distribution of myocardial blood flow in conscious pigs. Am J Physiol 276(2):H368-375. https:\/\/doi.org\/10.1152\/ajpheart.1999.276.2.H368","journal-title":"Am J Physiol"},{"key":"9856_CR74","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/j.1476-5381.1994.tb14877.x","volume":"111","author":"BF Cox","year":"1994","unstructured":"Cox BF, Greenland BD, Perrone MH, Merkel LA (1994) Ischaemia\/reperfusion selectively attenuates coronary vasodilatation to an adenosine A2- but not to an A1-agonist in the dog. Br J Pharmacol 111:1233\u20131239. https:\/\/doi.org\/10.1111\/j.1476-5381.1994.tb14877.x","journal-title":"Br J Pharmacol"},{"key":"9856_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.phrs.2013.08.007","volume":"77","author":"Z Zhou","year":"2013","unstructured":"Zhou Z, de Wijs-Meijler D, Lankhuizen I, Jankowski J, Jankowski V, Jan Danser AH, Duncker DJ, Merkus D (2013) Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation. Pharmacol Res 77:22\u201329. https:\/\/doi.org\/10.1016\/j.phrs.2013.08.007","journal-title":"Pharmacol Res"},{"issue":"1","key":"9856_CR76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00395-021-00859-7","volume":"116","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wernly B, Cao X, Mustafa SJ, Tang Y, Zhou Z (2021) Adenosine and adenosine receptor-mediated action in coronary microcirculation. Basic Res Cardiol 116(1):22. https:\/\/doi.org\/10.1007\/s00395-021-00859-7","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"9856_CR77","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cardiores.2006.06.011","volume":"71","author":"D G\u00fcnd\u00fcz","year":"2006","unstructured":"G\u00fcnd\u00fcz D, Kasseckert SA, H\u00e4rtel FV, Aslam M, Abdallah Y, Sch\u00e4fer M, Piper HM, Noll T, Sch\u00e4fer C (2006) Accumulation of extracellular ATP protects against acute reperfusion injury in rat heart endothelial cells. Cardiovasc Res 71(4):764\u2013773. https:\/\/doi.org\/10.1016\/j.cardiores.2006.06.011","journal-title":"Cardiovasc Res"},{"issue":"4","key":"9856_CR78","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000365928","volume":"51","author":"\u00c1L Garc\u00eda-Villal\u00f3n","year":"2014","unstructured":"Garc\u00eda-Villal\u00f3n \u00c1L, Granado M, Monge L, Fern\u00e1ndez N, Carre\u00f1o-Tarragona G, Amor S (2014) Purinergic component in the coronary vasodilatation to acetylcholine after ischemia-reperfusion in perfused rat hearts. J Vasc Res 51(4):283\u2013289. https:\/\/doi.org\/10.1159\/000365928","journal-title":"J Vasc Res"},{"issue":"6","key":"9856_CR79","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/14017431.2018.1552793","volume":"52","author":"SB Kristiansen","year":"2018","unstructured":"Kristiansen SB, Skovsted GF, Berchtold LA, Radziwon-Balicka A, Dreisig K, Edvinsson L, Sheykhzade M, Haanes KA (2018) Role of pannexin and adenosine triphosphate (ATP) following myocardial ischemia\/reperfusion. Scand Cardiovasc J 52(6):340\u2013343. https:\/\/doi.org\/10.1080\/14017431.2018.1552793","journal-title":"Scand Cardiovasc J"},{"issue":"15","key":"9856_CR80","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jcin.2015.08.033","volume":"8","author":"T Yetgin","year":"2015","unstructured":"Yetgin T, Uitterdijk A, Hekkert MTL, Merkus D, Krabbendam-Peters I, Beusekom HMM, Falotico R, Serruys P, Manintveld OC, Geuns RJM, Zijlstra F, Duncker DJ (2015) Limitation of infarct size and no-reflow by intracoronary adenosine depends critically on dose and duration. JACC Cardiovasc Interv 8(15):1990\u20131999. https:\/\/doi.org\/10.1016\/j.jcin.2015.08.033","journal-title":"JACC Cardiovasc Interv"},{"key":"9856_CR81","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijcard.2015.09.005","volume":"202","author":"H Bulluck","year":"2016","unstructured":"Bulluck H, Sirker A, Loke YK, Garcia-Dorado D, Hausenloy DJ (2016) Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials. Int J Cardiol 202:228\u2013237. https:\/\/doi.org\/10.1016\/j.ijcard.2015.09.005","journal-title":"Int J Cardiol"},{"issue":"3","key":"9856_CR82","doi-asserted-by":"publisher","first-page":"H1071","DOI":"10.1152\/ajpheart.2000.279.3.H1071","volume":"279","author":"RR Morrison","year":"2000","unstructured":"Morrison RR, Jones R, Byford AM, Stell AR, Peart J, Headrick JP, Matherne GP (2000) Transgenic overexpression of cardiac A(1) adenosine receptors mimics ischemic preconditioning. Am J Physiol Heart Circ Physiol 279(3):H1071-1078. https:\/\/doi.org\/10.1152\/ajpheart.2000.279.3.H1071","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"9856_CR83","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1139\/y05-038","volume":"83","author":"M Crawford","year":"2005","unstructured":"Crawford M, Ford S, Henry M, Matherne GP, Lankford A (2005) Myocardial function following cold ischemic storage is improved by cardiac-specific overexpression of A1-adenosine receptors. Can J Physiol Pharmacol 83(6):493\u2013498. https:\/\/doi.org\/10.1139\/y05-038","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"9856_CR84","doi-asserted-by":"publisher","first-page":"H859","DOI":"10.1152\/ajpheart.00251.2002","volume":"284","author":"SE Regan","year":"2003","unstructured":"Regan SE, Broad M, Byford AM, Lankford AR, Cerniway RJ, Mayo MW, Matherne GP (2003) A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity. Am J Physiol Heart Circ Physiol 284(3):H859-866. https:\/\/doi.org\/10.1152\/ajpheart.00251.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"9856_CR85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1006\/jmcc.2000.1275","volume":"33","author":"ZQ Zhao","year":"2001","unstructured":"Zhao ZQ, Budde JM, Morris C, Wang NP, Velez DA, Muraki S, Guyton RA, Vinten-Johansen J (2001) Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J Mol Cell Cardiol 33(1):57\u201368. https:\/\/doi.org\/10.1006\/jmcc.2000.1275","journal-title":"J Mol Cell Cardiol"},{"key":"9856_CR86","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.vph.2015.06.003","volume":"73","author":"M Granado","year":"2015","unstructured":"Granado M, Amor S, Montoya JJ, Monge L, Fern\u00e1ndez N, Garc\u00eda-Villal\u00f3n AL (2015) Altered expression of P2Y2 and P2X7 purinergic receptors in the isolated rat heart mediates ischemia-reperfusion injury. Vascul Pharmacol 73:96\u2013103. https:\/\/doi.org\/10.1016\/j.vph.2015.06.003","journal-title":"Vascul Pharmacol"},{"issue":"3","key":"9856_CR87","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jtcvs.2018.12.014","volume":"158","author":"T Bourguignon","year":"2019","unstructured":"Bourguignon T, Benoist L, Chadet S, Miquelestorena-Standley E, Fromont G, Ivanes F, Angoulvant D (2019) Stimulation of murine P2Y11-like purinoreceptor protects against hypoxia\/reoxygenation injury and decreases heart graft rejection lesions. J Thorac Cardiovasc Surg 158(3):780-790.e1. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.12.014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"9856_CR88","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.cir.74.5.1124","volume":"74","author":"CE Murry","year":"1986","unstructured":"Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74(5):1124\u20131136. https:\/\/doi.org\/10.1161\/01.cir.74.5.1124","journal-title":"Circulation"},{"issue":"6 Pt 2","key":"9856_CR89","doi-asserted-by":"publisher","first-page":"H1306","DOI":"10.1152\/ajpheart.1986.251.6.H1306","volume":"251","author":"KA Reimer","year":"1986","unstructured":"Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB (1986) Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 251(6 Pt 2):H1306-1315. https:\/\/doi.org\/10.1152\/ajpheart.1986.251.6.H1306","journal-title":"Am J Physiol"},{"issue":"3","key":"9856_CR90","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1161\/01.cir.88.3.1264","volume":"88","author":"MS Marber","year":"1993","unstructured":"Marber MS, Latchman DS, Walker JM, Yellon DM (1993) Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88(3):1264\u20131272. https:\/\/doi.org\/10.1161\/01.cir.88.3.1264","journal-title":"Circulation"},{"issue":"1","key":"9856_CR91","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0008-6363(97)00214-9","volume":"37","author":"DM Yellon","year":"1998","unstructured":"Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G, Sumeray MS (1998) Ischaemic preconditioning: present position and future directions. Cardiovasc Res 37(1):21\u201333. https:\/\/doi.org\/10.1016\/s0008-6363(97)00214-9","journal-title":"Cardiovasc Res"},{"issue":"4","key":"9856_CR92","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/0022-2828(95)90073-x","volume":"27","author":"K Mullane","year":"1995","unstructured":"Mullane K, Bullough D (1995) Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. J Mol Cell Cardiol 27(4):1041\u20131054. https:\/\/doi.org\/10.1016\/0022-2828(95)90073-x","journal-title":"J Mol Cell Cardiol"},{"issue":"5 Pt 2","key":"9856_CR93","doi-asserted-by":"publisher","first-page":"H1327","DOI":"10.1152\/ajpheart.1993.264.5.H1327","volume":"264","author":"JA Auchampach","year":"1993","unstructured":"Auchampach JA, Gross GJ (1993) Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol 264(5 Pt 2):H1327-1336. https:\/\/doi.org\/10.1152\/ajpheart.1993.264.5.H1327","journal-title":"Am J Physiol"},{"issue":"2","key":"9856_CR94","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF00374659","volume":"430","author":"R Schulz","year":"1995","unstructured":"Schulz R, Rose J, Post H, Heusch G (1995) Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch 430(2):273\u2013282. https:\/\/doi.org\/10.1007\/BF00374659","journal-title":"Pflugers Arch"},{"issue":"6","key":"9856_CR95","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/s0022-2828(05)82397-1","volume":"27","author":"DM Walker","year":"1995","unstructured":"Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM (1995) Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 27(6):1349\u20131357. https:\/\/doi.org\/10.1016\/s0022-2828(05)82397-1","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"9856_CR96","doi-asserted-by":"publisher","first-page":"H591","DOI":"10.1152\/ajpheart.2001.280.2.H591","volume":"280","author":"JD McCully","year":"2001","unstructured":"McCully JD, Toyoda Y, Uematsu M, Stewart RD, Levitsky S (2001) Adenosine-enhanced ischemic preconditioning: adenosine receptor involvement during ischemia and reperfusion. Am J Physiol Heart Circ Physiol 280(2):H591-602. https:\/\/doi.org\/10.1152\/ajpheart.2001.280.2.H591","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"9856_CR97","doi-asserted-by":"publisher","first-page":"H2694","DOI":"10.1152\/ajpheart.2000.279.6.H2694","volume":"279","author":"Y Toyoda","year":"2000","unstructured":"Toyoda Y, Friehs I, Parker RA, Levitsky S, McCully JD (2000) Differential role of sarcolemmal and mitochondrial K(ATP) channels in adenosine-enhanced ischemic preconditioning. Am J Physiol Heart Circ Physiol 279(6):H2694-2703. https:\/\/doi.org\/10.1152\/ajpheart.2000.279.6.H2694","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"9856_CR98","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00395-007-0687-7","volume":"103","author":"MV Cohen","year":"2008","unstructured":"Cohen MV, Downey JM (2008) Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol 103(3):203\u2013215. https:\/\/doi.org\/10.1007\/s00395-007-0687-7","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"9856_CR99","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0008-6363(01)00358-3","volume":"52","author":"K Mubagwa","year":"2001","unstructured":"Mubagwa K, Flameng W (2001) Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52(1):25\u201339. https:\/\/doi.org\/10.1016\/s0008-6363(01)00358-3","journal-title":"Cardiovasc Res"},{"issue":"3","key":"9856_CR100","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/01.res.81.3.415","volume":"81","author":"E Giannella","year":"1997","unstructured":"Giannella E, Mochmann HC, Levi R (1997) Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia\/reperfusion: role of adenosine A1\/A3 and bradykinin B2 receptor activation. Circ Res 81(3):415\u2013422. https:\/\/doi.org\/10.1161\/01.res.81.3.415","journal-title":"Circ Res"},{"issue":"4","key":"9856_CR101","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1006\/jmcc.2001.1338","volume":"33","author":"Y Guo","year":"2001","unstructured":"Guo Y, Bolli R, Bao W, Wu WJ, Black RG Jr, Murphree SS, Salvatore CA, Jacobson MA, Auchampach JA (2001) Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning. J Mol Cell Cardiol 33(4):825\u2013830. https:\/\/doi.org\/10.1006\/jmcc.2001.1338","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"9856_CR102","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/s0003-4975(99)01018-8","volume":"68","author":"J Vinten-Johansen","year":"1999","unstructured":"Vinten-Johansen J, Thourani VH, Ronson RS, Jordan JE, Zhao ZQ, Nakamura M, Velez D, Guyton RA (1999) Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 68(5):1942\u20131948. https:\/\/doi.org\/10.1016\/s0003-4975(99)01018-8","journal-title":"Ann Thorac Surg"},{"issue":"3\u20134","key":"9856_CR103","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10741-007-9025-2","volume":"12","author":"JM Downey","year":"2007","unstructured":"Downey JM, Davis AM, Cohen MV (2007) Signaling pathways in ischemic preconditioning. Heart Fail Rev 12(3\u20134):181\u2013188. https:\/\/doi.org\/10.1007\/s10741-007-9025-2","journal-title":"Heart Fail Rev"},{"key":"9856_CR104","doi-asserted-by":"publisher","unstructured":"Tian Y, Piras BA, Kron IL, French BA, Yang Z (2015) Adenosine 2B receptor activation reduces myocardial reperfusion injury by promoting anti-inflammatory macrophages differentiation via PI3K\/Akt pathway. Oxid Med Cell Longev 2015: 585297https:\/\/doi.org\/10.1155\/2015\/585297","DOI":"10.1155\/2015\/585297"},{"issue":"5","key":"9856_CR105","doi-asserted-by":"publisher","first-page":"H2253","DOI":"10.1152\/ajpheart.01009.2004","volume":"288","author":"EA Reid","year":"2005","unstructured":"Reid EA, Kristo G, Yoshimura Y, Ballard-Croft C, Keith BJ, Mentzer RM Jr, Lasley RD (2005) In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling. Am J Physiol Heart Circ Physiol 288(5):H2253-2259. https:\/\/doi.org\/10.1152\/ajpheart.01009.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"9856_CR106","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.cir.87.3.893","volume":"87","author":"K Przyklenk","year":"1993","unstructured":"Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P (1993) Regional ischemic \u2018preconditioning\u2019 protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87(3):893\u2013899. https:\/\/doi.org\/10.1161\/01.cir.87.3.893","journal-title":"Circulation"},{"issue":"2","key":"9856_CR107","doi-asserted-by":"publisher","first-page":"H579","DOI":"10.1152\/ajpheart.01064.2002","volume":"285","author":"ZQ Zhao","year":"2003","unstructured":"Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285(2):H579-588. https:\/\/doi.org\/10.1152\/ajpheart.01064.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"9856_CR108","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10557-011-6364-y","volume":"26","author":"DJ Hausenloy","year":"2012","unstructured":"Hausenloy DJ, Iliodromitis EK, Andreadou I, Papalois A, Gritsopoulos G, Anastasiou-Nana M, Kremastinos DT, Yellon DM (2012) Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart. Cardiovasc Drugs Ther 26(2):87\u201393. https:\/\/doi.org\/10.1007\/s10557-011-6364-y","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"9856_CR109","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1089\/ars.2010.3318","volume":"14","author":"MV Cohen","year":"2011","unstructured":"Cohen MV, Downey JM (2011) Ischemic postconditioning: from receptor to end-effector. Antioxid Redox Signal 14(5):821\u2013831. https:\/\/doi.org\/10.1089\/ars.2010.3318","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"9856_CR110","doi-asserted-by":"publisher","first-page":"e0179349","DOI":"10.1371\/journal.pone.0179349","volume":"12","author":"M Tscharre","year":"2017","unstructured":"Tscharre M, Egger F, Machata M, Rohla M, Michael N, Neumayr M, Zweiker R, Hajos J, Adlbrecht C, Suppan M, Helmreich W, Eber B, Huber K, Weiss TW (2017) Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: a prospective, multi-centre registry. PLoS One 12(6):e0179349. https:\/\/doi.org\/10.1371\/journal.pone.0179349","journal-title":"PLoS One"},{"issue":"6","key":"9856_CR111","doi-asserted-by":"publisher","first-page":"e20210008","DOI":"10.1084\/jem.20210008","volume":"218","author":"J Li","year":"2021","unstructured":"Li J, Conrad C, Mills TW, Berg NK, Kim B, Ruan W, Lee JW, Zhang X, Yuan X, Eltzschig HK (2021) PMN-derived netrin-1 attenuates cardiac ischemia-reperfusion injury via myeloid ADORA2B signaling. J Exp Med 218(6):e20210008. https:\/\/doi.org\/10.1084\/jem.20210008","journal-title":"J Exp Med"},{"issue":"10","key":"9856_CR112","doi-asserted-by":"publisher","first-page":"H1287","DOI":"10.1152\/ajpheart.00835.2014","volume":"308","author":"M Ihara","year":"2015","unstructured":"Ihara M, Asanuma H, Yamazaki S, Kato H, Asano Y, Shinozaki Y, Mori H, Minamino T, Asakura M, Sugimachi M, Mochizuki N, Kitakaze M (2015) An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 308(10):H1287-1297. https:\/\/doi.org\/10.1152\/ajpheart.00835.2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"9856_CR113","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1472-8206.2009.00677.x","volume":"23","author":"H Millart","year":"2009","unstructured":"Millart H, Alouane L, Oszust F, Chevallier S, Robinet A (2009) Involvement of P2Y receptors in pyridoxal-5\u2019-phosphate-induced cardiac preconditioning. Fundam Clin Pharmacol 23(3):279\u2013292. https:\/\/doi.org\/10.1111\/j.1472-8206.2009.00677.x","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"9856_CR114","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1515\/cclm-2012-0553","volume":"51","author":"NS Dhalla","year":"2013","unstructured":"Dhalla NS, Takeda S, Elimban V (2013) Mechanisms of the beneficial effects of vitamin B6 and pyridoxal 5-phosphate on cardiac performance in ischemic heart disease. Clin Chem Lab Med 51(3):535\u2013543. https:\/\/doi.org\/10.1515\/cclm-2012-0553","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"9856_CR115","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/cvr\/cvv121","volume":"106","author":"Y Tang","year":"2015","unstructured":"Tang Y, Wang Y, Park KM, Hu Q, Teoh JP, Broskova Z, Ranganathan P, Jayakumar C, Li J, Su H, Tang Y, Ramesh G, Kim IM (2015) MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death. Cardiovasc Res 106(3):387\u2013397. https:\/\/doi.org\/10.1093\/cvr\/cvv121","journal-title":"Cardiovasc Res"},{"issue":"5","key":"9856_CR116","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/FJC.0b013e31819fd4e7","volume":"53","author":"M Paiva","year":"2009","unstructured":"Paiva M, Riksen NP, Davidson SM, Hausenloy DJ, Monteiro P, Goncalves L, Provid\u00eancia L, Rongen GA, Smits P, Mocanu MM, Yellon DM (2009) Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. J Cardiovasc Pharmacol 53(5):373\u2013378. https:\/\/doi.org\/10.1097\/FJC.0b013e31819fd4e7","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"9856_CR117","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1440-1681.2011.05550.x","volume":"38","author":"Y Bai","year":"2011","unstructured":"Bai Y, Muqier MH, Iwasa M, Sumi S, Yamada Y, Ushikoshi H, Aoyama T, Nishigaki K, Takemura G, Uno B, Minatoguchi S (2011) Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels. Clin Exp Pharmacol Physiol 38(10):658\u2013665. https:\/\/doi.org\/10.1111\/j.1440-1681.2011.05550.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"9856_CR118","doi-asserted-by":"publisher","first-page":"H2091","DOI":"10.1152\/ajpheart.1999.277.5.H2091","volume":"277","author":"VM Figueredo","year":"1999","unstructured":"Figueredo VM, Diamond I, Zhou HZ, Camacho SA (1999) Chronic dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury. Am J Physiol 277(5):H2091-2097. https:\/\/doi.org\/10.1152\/ajpheart.1999.277.5.H2091","journal-title":"Am J Physiol"},{"issue":"3","key":"9856_CR119","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1053\/j.jvca.2010.05.012","volume":"25","author":"L Yao","year":"2011","unstructured":"Yao L, Wong GTC, Xia ZY, Irwin MG (2011) Interaction between spinal opioid and adenosine receptors in remote cardiac preconditioning: effect of intrathecal morphine. J Cardiothorac Vasc Anesth 25(3):444\u2013448. https:\/\/doi.org\/10.1053\/j.jvca.2010.05.012","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"9856_CR120","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jss.2015.01.010","volume":"195","author":"JY Ha","year":"2015","unstructured":"Ha JY, Lee YC, Park SJ, Jang YH, Kim JH (2015) Remifentanil postconditioning has cross talk with adenosine receptors in the ischemic-reperfused rat heart. J Surg Res 195(1):37\u201343. https:\/\/doi.org\/10.1016\/j.jss.2015.01.010","journal-title":"J Surg Res"},{"issue":"1","key":"9856_CR121","doi-asserted-by":"publisher","first-page":"H81","DOI":"10.1152\/ajpheart.00985.2002","volume":"285","author":"JN Peart","year":"2003","unstructured":"Peart JN, Gross GJ (2003) Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. Am J Physiol Heart Circ Physiol 285(1):H81-89. https:\/\/doi.org\/10.1152\/ajpheart.00985.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"9856_CR122","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10557-016-6701-2","volume":"30","author":"Y Birnbaum","year":"2016","unstructured":"Birnbaum Y, Birnbaum GD, Birnbaum I, Nylander S, Ye Y (2016) Ticagrelor and rosuvastatin have additive cardioprotective effects via adenosine. Cardiovasc Drugs Ther 30(6):539\u2013550. https:\/\/doi.org\/10.1007\/s10557-016-6701-2","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"9856_CR123","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00395-018-0692-z","volume":"113","author":"JP Audia","year":"2018","unstructured":"Audia JP, Yang XM, Crockett ES, Housley N, Haq EU, O\u2019Donnell K, Cohen MV, Downey JM, Alvarez DF (2018) Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function. Basic Res Cardiol 113(5):32. https:\/\/doi.org\/10.1007\/s00395-018-0692-z","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"9856_CR124","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jamcollsurg.2004.05.274","volume":"199","author":"G Kristo","year":"2004","unstructured":"Kristo G, Yoshimura Y, Ferraris SP, Jahania SA, Mentzer RM Jr, Lasley RD (2004) The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size. J Am Coll Surg 199(4):586\u2013594. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2004.05.274","journal-title":"J Am Coll Surg"},{"issue":"5","key":"9856_CR125","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10557-013-6474-9","volume":"27","author":"XM Yang","year":"2013","unstructured":"Yang XM, Cui L, Alhammouri A, Downey JM, Cohen MV (2013) Triple therapy greatly increases myocardial salvage during ischemia\/reperfusion in the in situ rat heart. Cardiovasc Drugs Ther 27(5):403\u2013412. https:\/\/doi.org\/10.1007\/s10557-013-6474-9","journal-title":"Cardiovasc Drugs Ther"},{"issue":"11","key":"9856_CR126","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/ptr.4899","volume":"27","author":"XF Yan","year":"2013","unstructured":"Yan XF, Zhang ZM, Yao HY, Guan Y, Zhu JP, Zhang LH, Jia YL, Wang RW (2013) Cardiovascular protection and antioxidant activity of the extracts from the mycelia of Cordyceps sinensis act partially via adenosine receptors. Phytother Res 27(11):1597\u20131604. https:\/\/doi.org\/10.1002\/ptr.4899","journal-title":"Phytother Res"},{"issue":"1\u20132","key":"9856_CR127","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0014-2999(03)01441-9","volume":"465","author":"S Bradamante","year":"2003","unstructured":"Bradamante S, Barenghi L, Piccinini F, Bertelli AAE, Jonge RD, Beemster P, Jong JWD (2003) Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur J Pharmacol 465(1\u20132):115\u2013123. https:\/\/doi.org\/10.1016\/s0014-2999(03)01441-9","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"9856_CR128","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10557-008-6105-z","volume":"22","author":"Y Ye","year":"2008","unstructured":"Ye Y, Abu Said GH, Lin Y, Manickavasagam S, Hughes MG, McAdoo DJ, Perez-Polo RJ, Birnbaum Y (2008) Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat. Cardiovasc Drugs Ther 22(4):275\u2013282. https:\/\/doi.org\/10.1007\/s10557-008-6105-z","journal-title":"Cardiovasc Drugs Ther"},{"issue":"7","key":"9856_CR129","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1073\/pnas.94.7.3235","volume":"94","author":"M Miyamae","year":"1997","unstructured":"Miyamae M, Diamond I, Weiner MW, Camacho SA, Figueredo VM (1997) Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci U S A 94(7):3235\u20133239. https:\/\/doi.org\/10.1073\/pnas.94.7.3235","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9856_CR130","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.res.82.3.346","volume":"82","author":"Y Ishibashi","year":"1998","unstructured":"Ishibashi Y, Duncker DJ, Zhang J, Bache RJ (1998) ATP-sensitive K+ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res 82(3):346\u2013359. https:\/\/doi.org\/10.1161\/01.res.82.3.346","journal-title":"Circ Res"},{"key":"9856_CR131","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3389\/fphys.2019.01286","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen X, Li H, Wang K, Liang X, Wang W, Hu X, Huang Z, Wang Y (2019) Aerobic exercise ameliorates myocardial inflammation, fibrosis and apoptosis in high-fat-diet rats by inhibiting P2X7 purinergic receptors. Front Physiol 10:1286. https:\/\/doi.org\/10.3389\/fphys.2019.01286","journal-title":"Front Physiol"},{"key":"9856_CR132","doi-asserted-by":"publisher","first-page":"110148","DOI":"10.1016\/j.biopha.2020.110148","volume":"127","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Chen W, Zhong Z, Ding L, Bai H, Chen H, Zhang H, Gu Y, Lu S (2020) Electroacupuncture preconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting mitophagy mediated by the mTORC1-ULK1-FUNDC1 pathway. Biomed Pharmacother 127:110148. https:\/\/doi.org\/10.1016\/j.biopha.2020.110148","journal-title":"Biomed Pharmacother"},{"key":"9856_CR133","doi-asserted-by":"publisher","unstructured":"Xiao N, Li Y, Shao ML, Cui HF, Zhang CY, Kong SP, Zhang X, Yu HJ, Tan QW (2020) Jiaji (EX-B2)-based electroacupuncture preconditioning attenuates early ischaemia reperfusion injury in the rat myocardium. Evid Based Complement Alternat Med 2020: 8854033https:\/\/doi.org\/10.1155\/2020\/8854033","DOI":"10.1155\/2020\/8854033"},{"issue":"4","key":"9856_CR134","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.mehy.2009.05.031","volume":"73","author":"G Burnstock","year":"2009","unstructured":"Burnstock G (2009) Acupuncture: a novel hypothesis for the involvement of purinergic signalling. Med Hypotheses 73(4):470\u2013472. https:\/\/doi.org\/10.1016\/j.mehy.2009.05.031","journal-title":"Med Hypotheses"},{"issue":"3","key":"9856_CR135","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1142\/s0192415x21500294","volume":"49","author":"ZY Lv","year":"2021","unstructured":"Lv ZY, Yang YQ, Yin LM (2021) Role of purinergic signaling in acupuncture therapeutics. Am J Chin Med 49(3):645\u2013659. https:\/\/doi.org\/10.1142\/s0192415x21500294","journal-title":"Am J Chin Med"},{"issue":"1","key":"9856_CR136","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11302-020-09729-8","volume":"17","author":"Y Tang","year":"2021","unstructured":"Tang Y, Illes P (2021) Tribute to Prof. Geoffrey Burnstock: his contribution to acupuncture. Purinergic Signal 17(1):71\u201377. https:\/\/doi.org\/10.1007\/s11302-020-09729-8","journal-title":"Purinergic Signal"},{"issue":"9","key":"9856_CR137","doi-asserted-by":"publisher","first-page":"576","DOI":"10.13702\/j.1000-0607.180089","volume":"43","author":"QF Dai","year":"2018","unstructured":"Dai QF, Wang YY, Liu Q, Xin JJ, Lu FY, Cui JJ, Wu SY, Zhou C, Zhao YX, Gao JH, Yu XC (2018) A potential role of adenosine A2b receptor in mediating acupuncture pretreatment induced cardioprotection via influencing intracellular calcium regulator. Zhen Ci Yan Jiu 43(9):576\u2013580. https:\/\/doi.org\/10.13702\/j.1000-0607.180089","journal-title":"Zhen Ci Yan Jiu"},{"issue":"3","key":"9856_CR138","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11302-020-09704-3","volume":"16","author":"Y Ren","year":"2020","unstructured":"Ren Y, Chen Z, Wang R, Yu Y, Li D, He Y (2020) Electroacupuncture improves myocardial ischemia injury via activation of adenosine receptors. Purinergic Signal 16(3):337\u2013345. https:\/\/doi.org\/10.1007\/s11302-020-09704-3","journal-title":"Purinergic Signal"},{"issue":"2","key":"9856_CR139","doi-asserted-by":"publisher","first-page":"173","DOI":"10.13703\/j.0255-2930.2018.02.019","volume":"38","author":"S Lu","year":"2018","unstructured":"Lu S, Tang Y, Ding Y, Yu M, Fu S, Zhu B (2018) Effects of electroacupuncture on the expression of adenosine receptors in the heart tissue of myocardial ischemia rats. Zhongguo Zhen Jiu 38(2):173\u2013179. https:\/\/doi.org\/10.13703\/j.0255-2930.2018.02.019","journal-title":"Zhongguo Zhen Jiu"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09856-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-022-09856-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09856-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T12:21:09Z","timestamp":1677846069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-022-09856-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["9856"],"URL":"https:\/\/doi.org\/10.1007\/s11302-022-09856-4","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}